3 min read

How Affordability Programs Can Change Lives

Read how to help patients overcome financial hurdles to therapeutic access.

Facing a sudden illness is a challenge that nobody, including their family, can truly prepare for. I speak from experience as my father was diagnosed with stage 4 lung cancer. He was on several monthly maintenance medications already, and adding weekly chemo treatments and many, many appointments was not something that he was able to afford.

Not being able to afford medical care or medication has a major impact on at least 22% of the patient population. Patients know that whatever the diagnosis, they may not be able to afford the cost of care, or even the prescribed medications. This usually hinders their ability to get a diagnosis and begin treatment.

My experience in the pharmaceutical industry for over 20 years was a blessing. I knew there were programs out there that may be able to assist him during this difficult time. Most patients are not aware of affordability programs that may be able to help them with the cost of their medications. He was fortunate enough to have been approved into a Patient Assistance program (PAP) and a copay assistance card which helped to alleviate some of the financial burden.

UBC offers affordability programs aimed at helping patients overcome their financial hurdles. As a key partner in the pharmaceutical industry, advocating for our patients is such an integral part of what we do to help support them along their healthcare journey. We create customizable affordability programs, while also addressing the needs and requirements of caregivers, prescribers, pharmacists, and payers. In partnership with our clients, we create optimal patient programs designed to assist with financial obstacles and improve speed to therapy. Contact UBC today to design an affordability program that enables your patients to effectively navigate their journey.


Dawn Erb is Director, Program Management at UBC.  With over 27 years of experience in the pharmaceutical space, she has executed many patient affordability programs including Patient Assistance (PAP), Reimbursement, and Copay Savings programs. She has assisted in the design and implementation of patient programs allowing patients to gain access to therapy while also maintaining patient adherence. Dawn brings a breadth of experience and knowledge in the development and implementation of programs for both patients and providers. Dawn has dedicated her career to facilitating access to medications for patients who cannot otherwise afford them.

Other Recent Posts

3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.